Filing Details
- Accession Number:
- 0000028823-19-000185
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-10-31 13:51:57
- Reporting Period:
- 2019-10-31
- Accepted Time:
- 2019-10-31 13:51:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
28823 | Diebold Nixdorf Inc | DBD | Calculating & Accounting Machines (No Electronic Computers) (3578) | 340183970 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1686746 | Robert Olaf Heyden | C/O Diebold Nixdorf, Incorporated 5995 Mayfair Rd. North Canton OH 44720 | Svp, Services | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Acquisiton | 2019-10-31 | 1,000 | $6.98 | 160,202 | No | 4 | P | Direct | |
Common Shares | Acquisiton | 2019-10-31 | 1,000 | $6.99 | 161,202 | No | 4 | A | Direct | |
Common Shares | Acquisiton | 2019-10-31 | 8,730 | $6.99 | 169,932 | No | 4 | A | Direct | |
Common Shares | Acquisiton | 2019-10-31 | 5 | $7.08 | 169,937 | No | 4 | A | Direct | |
Common Shares | Acquisiton | 2019-10-31 | 1,800 | $7.01 | 171,737 | No | 4 | A | Direct | |
Common Shares | Acquisiton | 2019-10-31 | 1,000 | $6.98 | 172,737 | No | 4 | A | Direct | |
Common Shares | Acquisiton | 2019-10-31 | 1,000 | $6.99 | 173,737 | No | 4 | A | Direct | |
Common Shares | Acquisiton | 2019-10-31 | 1,782 | $6.97 | 175,519 | No | 4 | A | Direct | |
Common Shares | Acquisiton | 2019-10-31 | 3,683 | $6.99 | 179,202 | No | 4 | A | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | A | Direct | |
No | 4 | A | Direct | |
No | 4 | A | Direct | |
No | 4 | A | Direct | |
No | 4 | A | Direct | |
No | 4 | A | Direct | |
No | 4 | A | Direct | |
No | 4 | A | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Shares | 1,000 | Indirect | By Spouse |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Shares | Non-Qualified Stock Options | $26.60 | 2018-02-08 | 2027-02-07 | 49,650 | 49,650 | Direct |
Common Shares | Non-Qualified Stock Option | $18.75 | 2019-02-01 | 2028-02-01 | 30,278 | 30,278 | Direct |
Common Shares | Non-Qualified Stock Option | $4.08 | 2020-01-29 | 2029-01-29 | 47,407 | 47,407 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2027-02-07 | 49,650 | 49,650 | Direct |
2028-02-01 | 30,278 | 30,278 | Direct |
2029-01-29 | 47,407 | 47,407 | Direct |
Footnotes
- Original purchase price was EUR 6.264. USD amount based on the currency exchange rate for purchase date.
- Number includes restricted stock units.
- Original purchase price was EUR 6.272. USD amount based on the currency exchange rate for purchase date.
- Original purchase price was EUR 6.27. USD amount based on the currency exchange rate for purchase date.
- Original purchase price was EUR 6.35. USD amount based on the currency exchange rate for purchase date.
- Original purchase price was EUR 6.292. USD amount based on the currency exchange rate for purchase date.
- Original purchase price was EUR 6.26. USD amount based on the currency exchange rate for purchase date.
- Original purchase price was EUR 6.268. USD amount based on the currency exchange rate for purchase date.
- Original purchase price was EUR 6.256. USD amount based on the currency exchange rate for purchase date.
- Granted under the 1991 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.
- Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.